Avantor Inc. (AVTR) PT Lowered to $13 at UBS

UBS analyst Dan Leonard lowered the price target on Avantor Inc. (NYSE: AVTR) to $13.00 (from $14.00) while maintaining a Neutral rating.

The analyst commented, "Our Neutral rating on Avantor (AVTR) reflects our view that outsized exposure to market headwinds and channel share risks could depress sales growth below industry peers' (by 2%+ over a cycle), while broader considerations (higher interest rates, higher target valuations, a high relative debt burden) could complicate efforts to structurally accelerate sales growth. Avantor's below market bioprocessing results and guidance reductions in organic sales and adj. EBITDA support our thesis."

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• JPMorgan Downgrades HomeCo Daily Needs REIT (HDN:AU) to Neutral
• Nomura/Instinet Downgrades Korea Electric Power Corp. (015760:KS) (KEP) to Neutral